Trial Profile
An Open-label, Single-arm Study to Determine the Excretion balance and Metabolic Disposition of [14C]GW642444 administered as a Single Dose of an Oral Solution to Healthy Male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Vilanterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors GSK
- 10 Feb 2011 New trial record